Loading…
Lobbying Spend
—
Filings
18
Firms Hired
1
Active Period
2011–2014
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Medicaid issues and the Orphan Drug Act; FDA issues surrounding pharmacy compounding, specifically H.R. 3204, the Drug Quality and Safety Act
Client expense: — · Firm income: $20,000
Matched citations: H.R. 3204
Medicaid issues and the Orphan Drug Act; FDA issues surrounding pharmacy compounding, specifically H.R. 3204, the Drug Quality and Safety Act
Client expense: — · Firm income: $250,000
Matched citations: H.R. 3204
Medicaid issues and the Orphan Drug Act; FDA issues surrounding pharmacy compounding, specifically H.R. 3204, the Drug Quality and Safety Act
Client expense: — · Firm income: $250,000
Matched citations: H.R. 3204
Medicaid issues and the Orphan Drug Act; FDA issues surrounding pharmacy compounding, specifically H.R. 3204, the Drug Quality and Safety Act
Client expense: — · Firm income: $280,000
Matched citations: H.R. 3204
Medicaid issues and the Orphan Drug Act; FDA issues surrounding pharmacy compounding, specifically S.959, the Pharmaceutical Compounding Quality and Accountability Act, H.R. 2186, the Verifying Authority and Legality in Drug Compounding Act of 2013; H.R. 3204, the Drug Quality and Safety Act
Client expense: — · Firm income: $120,000
Matched citations: H.R. 2186
Medicaid issues and the Orphan Drug Act; FDA issues surrounding pharmacy compounding, specifically S.959, the Pharmaceutical Compounding Quality and Accountability Act, H.R. 2186, the Verifying Authority and Legality in Drug Compounding Act of 2013; H.R. 3204, the Drug Quality and Safety Act
Client expense: — · Firm income: $120,000
Matched citations: H.R. 3204
Pharmaceutical Quality, Security, and Accountability Act
2013 · third_quarter · Firm: DENTONS US LLP
Medicaid issues and the Orphan Drug Act; FDA issues surrounding pharmacy compounding, specifically S.959, the Pharmaceutical Compounding Quality and Accountability Act, H.R. 2186, the Verifying Authority and Legality in Drug Compounding Act of 2013; H.R. 3204, the Drug Quality and Safety Act
Client expense: — · Firm income: $120,000
Matched citations: S.959
Medicaid issues and the Orphan Drug Act,; FDA issues surrounding pharmacy compounding, specifically S.959, the Pharmaceutical Compounding Quality and Accountability Act, H.R. 2186, the Verifying Authority and Legality in Drug Compounding Act of 2013
Client expense: — · Firm income: $90,000
Matched citations: H.R. 2186
Pharmaceutical Quality, Security, and Accountability Act
2013 · second_quarter · Firm: DENTONS US LLP
Medicaid issues and the Orphan Drug Act,; FDA issues surrounding pharmacy compounding, specifically S.959, the Pharmaceutical Compounding Quality and Accountability Act, H.R. 2186, the Verifying Authority and Legality in Drug Compounding Act of 2013
Client expense: — · Firm income: $90,000
Matched citations: S.959
Source: Senate LDA